Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6[S]

Cholesterol homeostasis is crucial for cellular function and organismal health. The key regulator for the cholesterol biosynthesis is sterol-regulatory element binding protein (SREBP)-2. The biochemical process and physiological function of SREBP-2 have been well characterized; however, it is not clear how this gene is epigenetically regulated. Here we have identified sirtuin (Sirt)6 as a critical factor for Srebp2 gene regulation. Hepatic deficiency of Sirt6 in mice leads to elevated cholesterol levels. On the mechanistic level, Sirt6 is recruited by forkhead box O (FoxO)3 to the Srebp2 gene promoter where Sirt6 deacetylates histone H3 at lysines 9 and 56, thereby promoting a repressive chromatin state. Remarkably, Sirt6 or FoxO3 overexpression improves hypercholesterolemia in diet-induced or genetically obese mice. In summary, our data suggest an important role of hepatic Sirt6 and FoxO3 in the regulation of cholesterol homeostasis.

[1]  R. Mostoslavsky,et al.  Sirt6 Regulates Tnf-Alpha Secretion Through Hydrolysis of Long-Chain Fatty Acyl Lysine , 2013 .

[2]  Yi Wang,et al.  Sirt6 regulates TNFα secretion via hydrolysis of long chain fatty acyl lysine , 2013, Nature.

[3]  R. Pi,et al.  Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF‐κB‐dependent transcriptional activity , 2013, British journal of pharmacology.

[4]  P. Puigserver,et al.  The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. , 2012, Molecular cell.

[5]  E. Wagner,et al.  Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin , 2012, Nature Cell Biology.

[6]  Lei Zhong,et al.  The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun , 2012, Nature Medicine.

[7]  G. Feldmann,et al.  The NAD+-dependent Histone Deacetylase SIRT6 Promotes Cytokine Production and Migration in Pancreatic Cancer Cells by Regulating Ca2+ Responses* , 2012, The Journal of Biological Chemistry.

[8]  C. Deng,et al.  Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant Mice* , 2012, The Journal of Biological Chemistry.

[9]  W. Shao,et al.  Expanding roles for SREBP in metabolism. , 2012, Cell metabolism.

[10]  S. Gygi,et al.  C. elegans SIRT6/7 Homolog SIR-2.4 Promotes DAF-16 Relocalization and Function during Stress , 2012, PLoS genetics.

[11]  R. Grimley,et al.  Over Expression of Wild Type or a Catalytically Dead Mutant of SIRTUIN 6 Does Not Influence NFκB Responses , 2012, PloS one.

[12]  A. Seluanov,et al.  Sirtuin 6 (SIRT6) rescues the decline of homologous recombination repair during replicative senescence , 2012, Proceedings of the National Academy of Sciences.

[13]  C. McCall,et al.  NAD+-dependent Sirtuin 1 and 6 Proteins Coordinate a Switch from Glucose to Fatty Acid Oxidation during the Acute Inflammatory Response* , 2012, The Journal of Biological Chemistry.

[14]  M. Budoff,et al.  The Evolution and Refinement of Traditional Risk Factors for Cardiovascular Disease , 2012, Cardiology in review.

[15]  Y. Cai,et al.  Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6 , 2012, FEBS letters.

[16]  P. Tontonoz,et al.  Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR , 2012, Nature Reviews Molecular Cell Biology.

[17]  L. Goedeke,et al.  Regulation of cholesterol homeostasis , 2012, Cellular and Molecular Life Sciences.

[18]  Ziv Bar-Joseph,et al.  The sirtuin SIRT6 regulates lifespan in male mice , 2012, Nature.

[19]  R. DePinho,et al.  Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice. , 2012, Endocrinology.

[20]  Timothy F. Osborne,et al.  SREBPs: metabolic integrators in physiology and metabolism , 2012, Trends in Endocrinology & Metabolism.

[21]  T. Shioda,et al.  A Conserved SREBP-1/Phosphatidylcholine Feedback Circuit Regulates Lipogenesis in Metazoans , 2011, Cell.

[22]  A. Seluanov,et al.  SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells , 2011, Cell cycle.

[23]  A. Seluanov,et al.  SIRT6 Promotes DNA Repair Under Stress by Activating PARP1 , 2011, Science.

[24]  Howard Y. Chang,et al.  Dynamic Chromatin Localization of Sirt6 Shapes Stress- and Aging-Related Transcriptional Networks , 2011, PLoS genetics.

[25]  G. Farrell,et al.  SREBP‐2: A link between insulin resistance, hepatic cholesterol, and inflammation in NASH , 2011, Journal of gastroenterology and hepatology.

[26]  R. DePinho,et al.  Hepatic FoxOs Regulate Lipid Metabolism via Modulation of Expression of the Nicotinamide Phosphoribosyltransferase Gene* , 2011, The Journal of Biological Chemistry.

[27]  K. Kuwano,et al.  Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[28]  M. Trauner,et al.  Nuclear receptors in liver disease , 2011, Hepatology.

[29]  Sun Woo Kim,et al.  Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats , 2011, PloS one.

[30]  T. Montine,et al.  Diabetes and insulin in regulation of brain cholesterol metabolism. , 2010, Cell metabolism.

[31]  L. Christiansen,et al.  Replication of an association of variation in the FOXO3A gene with human longevity using both case–control and longitudinal data , 2010, Aging cell.

[32]  J. Vaupel,et al.  Effects of FOXO genotypes on longevity: a biodemographic analysis. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[33]  F. Alt,et al.  Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity , 2010, Proceedings of the National Academy of Sciences.

[34]  Oksana Gavrilova,et al.  SIRT6 Deficiency Results in Severe Hypoglycemia by Enhancing Both Basal and Insulin-stimulated Glucose Uptake in Mice* , 2010, The Journal of Biological Chemistry.

[35]  R. Sato.  Sterol metabolism and SREBP activation. , 2010, Archives of biochemistry and biophysics.

[36]  S. Jackson,et al.  Human SIRT6 Promotes DNA End Resection Through CtIP Deacetylation , 2010, Science.

[37]  Xiaoling Xu,et al.  Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. , 2010, Cell metabolism.

[38]  T. Veenstra,et al.  SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism* , 2010, The Journal of Biological Chemistry.

[39]  P. Puigserver,et al.  Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. , 2010, Genes & development.

[40]  D. Accili,et al.  Hepatic FoxO1 Ablation Exacerbates Lipid Abnormalities during Hyperglycemia* , 2010, The Journal of Biological Chemistry.

[41]  N. Mitro,et al.  Effects of FoxO4 overexpression on cholesterol biosynthesis, triacylglycerol accumulation, and glucose uptake , 2010, Journal of Lipid Research.

[42]  Y. Kanfi,et al.  SIRT6 protects against pathological damage caused by diet‐induced obesity , 2010, Aging cell.

[43]  Orian S. Shirihai,et al.  The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α , 2010, Cell.

[44]  T. Veenstra,et al.  FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. , 2009, Cell metabolism.

[45]  Bo Yang,et al.  The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability , 2009, Cell cycle.

[46]  Or Gozani,et al.  Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6 , 2009, Cell cycle.

[47]  H. Fan,et al.  FSH and FOXO1 regulate genes in the sterol/steroid and lipid biosynthetic pathways in granulosa cells. , 2009, Molecular endocrinology.

[48]  R. Bellazzi,et al.  Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. , 2009, Rejuvenation research.

[49]  Stefan Schreiber,et al.  Association of FOXO3A variation with human longevity confirmed in German centenarians , 2009, Proceedings of the National Academy of Sciences.

[50]  Véronique Kruys,et al.  Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner , 2009, Nature Medicine.

[51]  Howard Y. Chang,et al.  SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span , 2009, Cell.

[52]  S. Guan,et al.  SIRT6 stabilizes DNA-dependent Protein Kinase at chromatin for DNA double-strand break repair , 2009, Aging.

[53]  H. H. Dong,et al.  FoxO1 integrates insulin signaling to VLDL production , 2008, Cell cycle.

[54]  Katsuhiko Yano,et al.  FOXO3A genotype is strongly associated with human longevity , 2008, Proceedings of the National Academy of Sciences.

[55]  C. Kahn,et al.  Hepatic insulin resistance directly promotes formation of cholesterol gallstones , 2008, Nature Medicine.

[56]  Howard Y. Chang,et al.  SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin , 2008, Nature.

[57]  G. Stephanopoulos,et al.  Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. , 2008, Cell metabolism.

[58]  A. Goldberg,et al.  FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. , 2007, Cell metabolism.

[59]  L. Guarente,et al.  SIRT1 deacetylates and positively regulates the nuclear receptor LXR. , 2007, Molecular cell.

[60]  R. DePinho,et al.  Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. , 2007, Cell metabolism.

[61]  Yonghong Xiao,et al.  FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis , 2007, Cell.

[62]  K. Heidenreich,et al.  FoxO1 Regulates Multiple Metabolic Pathways in the Liver , 2006, Journal of Biological Chemistry.

[63]  Pingfang Liu,et al.  Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6 , 2006, Cell.

[64]  F. Maxfield,et al.  Role of cholesterol and lipid organization in disease , 2005, Nature.

[65]  L. Guarente,et al.  Mouse Sir2 Homolog SIRT6 Is a Nuclear ADP-ribosyltransferase* , 2005, Journal of Biological Chemistry.

[66]  D. Reinberg,et al.  Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. , 2004, Molecular cell.

[67]  Jay D. Horton,et al.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[68]  J. Ericsson,et al.  Coactivator-Dependent Acetylation Stabilizes Members of the SREBP Family of Transcription Factors , 2003, Molecular and Cellular Biology.

[69]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[70]  Tatsuhiko Kodama,et al.  Sterol-dependent Transcriptional Regulation of Sterol Regulatory Element-binding Protein-2* , 1996, The Journal of Biological Chemistry.